Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/72625
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStevens, J.en
dc.contributor.authorHorowitz, M.en
dc.contributor.authorDeacon, C.en
dc.contributor.authorNauck, M.en
dc.contributor.authorRayner, C.en
dc.contributor.authorJones, K.en
dc.date.issued2012en
dc.identifier.citationAlimentary Pharmacology & Therapeutics, 2012; 36(4):379-390en
dc.identifier.issn0269-2813en
dc.identifier.issn1365-2036en
dc.identifier.urihttp://hdl.handle.net/2440/72625-
dc.description.abstractBACKGROUND: The rate of gastric emptying (GE) and subsequent release of the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are critical determinants of postprandial glycaemia in health and type 2 diabetes. Slowing of GE may be the dominant mechanism by which exogenous GLP-1, and some GLP-1 analogues, improve postprandial glycaemia. AIM: To determine the effect of sitagliptin on GE in healthy subjects, and the relationships between GE with glycaemia and incretin hormone secretion. METHODS: Fifteen volunteers (22.8 ± 0.7 years) were studied on two occasions following 2 days dosing with sitagliptin (100 mg/day) or placebo. GE (scintigraphy), glycaemia and plasma GLP-1 and GIP (total and intact), insulin and glucagon were measured for 240 min following a mashed potato meal (1808 kJ). RESULTS: There was no difference in GE between sitgaliptin and placebo [50% emptying time (T50): P = 0.4]. Mean blood glucose was slightly less (P = 0.02) on sitagliptin. Sitagliptin reduced plasma glucagon between 75 and 120 min (P < 0.05), and increased intact GLP-1 (P = 0.0002) and intact GIP (P = 0.0001) by approximately twofold, but reduced total GIP (P = 0.0003) and had no effect on total GLP-1 (P = 0.16) or insulin (P = 0.75). On sitagliptin the initial rise in blood glucose (r = -0.66, P = 0.008) and the intact GIP response (r = -0.66, P = 0.007) were inversely related, whereas the intact GLP-1 response was related directly (r = 0.52, P = 0.05) to the T50. CONCLUSIONS: While the effects of sitagliptin on glycaemic control are unlikely to relate to slowing of GE in healthy humans, the rate of GE is a significant determinant of postprandial glycaemia on sitagliptin.en
dc.description.statementofresponsibilityJ. E. Stevens, M. Horowitz, C. F. Deacon, M. Nauck, C. K. Rayner & K. L. Jonesen
dc.language.isoenen
dc.publisherBlackwell Publishing Ltden
dc.rights© 2012 Blackwell Publishing Ltd.en
dc.subjectHumans; Triazoles; Pyrazines; Gastric Inhibitory Polypeptide; Glucagon; Insulin; Blood Glucose; Gastric Emptying; Intestinal Absorption; Postprandial Period; Female; Male; Glucagon-Like Peptide 1; Dipeptidyl-Peptidase IV Inhibitors; Young Adulten
dc.titleThe effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled studyen
dc.typeJournal articleen
dc.identifier.rmid0020120893en
dc.identifier.doi10.1111/j.1365-2036.2012.05198.xen
dc.identifier.pubid23751-
pubs.library.collectionMedicine publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]en
dc.identifier.orcidRayner, C. [0000-0002-5527-256X]en
dc.identifier.orcidJones, K. [0000-0002-1155-5816]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.